SEN, Sukanta. Canagliflozin (Invokana®): a First-in-Class Anti-diabetic Drug. Journal of Drug Delivery and Therapeutics, India, v. 3, n. 3, p. 145–146, 2013. DOI: 10.22270/jddt.v3i3.490. Disponível em: https://jddtonline.info/index.php/jddt/article/view/490. Acesso em: 22 jan. 2026.